1Hagensee ME, Carter JJ, Wipf GC, et al. Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and Mucosal IgA antibodies[J ]. Virology, 1995, 206:174 - 182.
2Evans TG, Bonnez W, Rose RC, et al.A phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers [J].J Infect Dis, 2001, 183 (10) : 1485 -1493.
3Cornelison TL. Human papillomavirus genotype 16 vaccines for cervical cancer prophylaxis and treatment[J ]. Curr Opin Oncol, 2000, 12:466 - 473.
5Ling M, Kanayama Masahide, Roden R, et al. Preventative and therapeutic vaccines for Humam Papillomavirus - associated cervical cancers[J ] .J Biomed Sci, 2000, 7 : 341 - 356.
6Breitburd F, Kimbauer R, Hubbert NI, et al. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection[J ] .J Virol, 1995, 69:3959 - 3963.
7Kimbauer R, Chandrachud LM, O' Neil BW, et al. Virus - like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization[ J ]. Virology, 1996, 219 : 37 - 44.
8Suzich JA, Ghim SJ, Palmer - Hill Fj, et al.Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomavirus[J ]. Proc Natl Acad Sci USA, 1995,92:11553-11557.
9Luxton J, Shepherd P. Human Papillomavirus antigens and T - cell recognition[J ]. Curr Opin Infect Dis, 2001, 14 : 139 - 143.
10Nardelli - Haefliger D, Roden Richard, Balmelli C, et al. Mucosal but not parenteral immunization with purified Human Papillomavirus type16 virus - like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice[J] .J Virol, 1999, 73(11) :9609- 9613.
